These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31556336)

  • 1. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma.
    Todisco A; Internò V; Stucci LS; Ostuni C; Lovero D; D'Oronzo S; Mele F; Duda L; Palmirotta R; Silvestris F
    Int J Biol Markers; 2019 Dec; 34(4):421-426. PubMed ID: 31556336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
    Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in pulmonary enteric adenocarcinoma].
    Zuo Y; Bai H; Ying JM; Wang J
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):321-325. PubMed ID: 35448919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
    Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
    J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
    Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
    EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK rearrangement in lung adenocarcinoma with concurrent cervix and breast metastases: A case report.
    Chuang X; Chen Y; Yu P; Qiu X; Wang J; Qu X; Teng Y; Liu Y; Jin B
    Thorac Cancer; 2018 Nov; 9(11):1513-1518. PubMed ID: 30144282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Enteric Adenocarcinoma Harboring a BRAF G469V Mutation.
    Shimizu D; Yamamoto H; Shien K; Taniguchi K; Miyoshi K; Namba K; Mesaki K; Sugimoto S; Soh J; Yamane M; Toyooka S
    Acta Med Okayama; 2021 Dec; 75(6):759-762. PubMed ID: 34955547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
    Jurmeister P; Vollbrecht C; Behnke A; Frost N; Arnold A; Treue D; Rückert JC; Neudecker J; Schweizer L; Klauschen F; Horst D; Hummel M; Dietel M; von Laffert M
    Lung Cancer; 2019 Dec; 138():43-51. PubMed ID: 31634654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.
    Zhao L; Huang S; Liu J; Zhao J; Li Q; Wang HQ
    Medicine (Baltimore); 2017 Sep; 96(39):e8153. PubMed ID: 28953659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
    Wang CX; Liu B; Wang YF; Zhang RS; Yu B; Lu ZF; Shi QL; Zhou XJ
    Int J Clin Exp Pathol; 2014; 7(3):1266-74. PubMed ID: 24696747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary enteric adenocarcinoma: an overview.
    Palmirotta R; Lovero D; D'Oronzo S; Todisco A; Internò V; Mele F; Stucci LS; Silvestris F
    Expert Rev Mol Med; 2020 Apr; 22():e1. PubMed ID: 32340641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases.
    Fassi E; Mandruzzato M; Zamparini M; Bianchi S; Petrelli F; Baggi A; Alberti A; Grisanti S; Berruti A
    Lung Cancer; 2023 May; 179():107176. PubMed ID: 37015149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer.
    Machado-Rugolo J; Fabro AT; Ascheri D; Farhat C; Ab'Saber AM; de Sá VK; Nagai MA; Takagaki T; Terra R; Parra ER; Capelozzi VL
    Hum Pathol; 2019 Jan; 83():177-191. PubMed ID: 30218756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
    Garajová I; Funel N; Fiorentino M; Agostini V; Ferracin M; Negrini M; Frassineti GL; Gavelli G; Frampton AE; Biasco G; Giovannetti E
    Clin Epigenetics; 2015; 7():129. PubMed ID: 26677401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
    Jurmeister P; Schöler A; Arnold A; Klauschen F; Lenze D; Hummel M; Schweizer L; Bläker H; Pfitzner BM; Mamlouk S; Sers C; Denkert C; Stichel D; Frost N; Horst D; von Laffert M; Capper D
    Mod Pathol; 2019 Jun; 32(6):855-865. PubMed ID: 30723296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary enteric adenocarcinoma.
    Gong J; Fan Y; Lu H
    Transl Oncol; 2021 Aug; 14(8):101123. PubMed ID: 34000642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
    Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
    J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review.
    Xu X; Chen D; Wu X; Wang Q
    Front Oncol; 2022; 12():988625. PubMed ID: 36212391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.